

          -  Known hypersensitivity to HCQ or other 4-aminoquinoline compounds

          -  Currently hospitalized

          -  Symptomatic with subjective fever, cough, or sore throat

          -  Current medications exclude concomitant use of HCQ

          -  Concomitant use of other anti-malarial treatment or chemoprophylaxis

          -  History of retinopathy of any etiology

          -  Psoriasis

          -  Porphyria

          -  Known bone marrow disorders with significant neutropenia (polymorphonuclear leukocytes
             < 1500) or thrombocytopenia (< 100 K)

          -  Concomitant use of digoxin, cyclosporin, cimetidine, or tamoxifen

          -  Known liver disease

          -  Known long QT syndrome

          -  Use of any investigational or non-registered drug or vaccine within 30 days preceding
             the first dose of the study drugs, or planned use during the study period
      